SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Amex: HTI - News), a biopharmaceutical company developing and commercializing recombinant human enzymes, today announced that it will release financial results for the three months ended March 31, 2007 after market close on Thursday, May 10, 2007.
